Home > PE Ratio > VAISHALI PHARMA

VAISHALI PHARMA
PE (Price/Earnings) Ratio

The Current P/E Ratio of VAISHALI PHARMA is 512.46.

Share Price ₹16.7Feb 07,2025
Market Cap ₹217.3 Cr
Earnings-TTM₹0.4 CrTTM-Standalone Results
Price/Earnings512.46xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for VAISHALI PHARMA
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of VAISHALI PHARMA

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of VAISHALI PHARMA is calculated as :

Current Market Cap [ ₹217.3 Cr] as on Feb 07,2025

(/) Earnings [ ₹0.4 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 512.46x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for VAISHALI PHARMA , the investors are currently willing to pay 512.46 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VAISHALI PHARMA !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of VAISHALI PHARMA over the last five years.

Historical PE (Price/Earnings) ratio chart of VAISHALI PHARMA


PE Ratio Performance Analysis for VAISHALI PHARMA

- VAISHALI PHARMA 's latest p/e ratio is 512.46x.

- VAISHALI PHARMA 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 272.35x.

- VAISHALI PHARMA 's operated at median p/e ratio of 20.88x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, VAISHALI PHARMA 's p/e ratio peaked in Mar2020 at 1288.35x.

- VAISHALI PHARMA 's p/e ratio hit its five-year low in Mar2023 of 2.33x.


How does VAISHALI PHARMA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
VAISHALI PHARMA 0.42512.46217.3
SUN PHARMACEUTICAL INDUSTRIES LTD11,486.0036.55419,764.0
CIPLA LTD5,000.4323.78118,905.0
DR REDDYS LABORATORIES LTD5,428.6019.07103,523.0
ZYDUS LIFESCIENCES LTD4,591.8021.78100,015.0
DIVIS LABORATORIES LTD2,067.0078.86163,010.0
MANKIND PHARMA LTD2,050.7350.67103,904.0
TORRENT PHARMACEUTICALS LTD1,862.0059.24110,313.0
LUPIN LTD2,651.9437.86100,405.0
AUROBINDO PHARMA LTD3,500.2519.7769,214.1
ABBOTT INDIA LTD1,334.4647.4563,315.3

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VAISHALI PHARMA 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 19.07x
Max industry PE 512.46x
Median industry PE 37.86x
Average industry PE 82.50x



You may also like the below Video Courses